Jaguar Animal Health (JAGX) Gains After Announcing Additional Topline Results from Study of Second-Gen. Formulation of Neonorm Calf
Go back to Jaguar Animal Health (JAGX) Gains After Announcing Additional Topline Results from Study of Second-Gen. Formulation of Neonorm Calf(NASDAQ: JAGX) | Delayed: 0.18 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.18 | 52 Week High | $4.60 | |||
Open | $0.18 | 52 Week Low | $0.81 | |||
Day High | $0.18 | P/E | N/A | |||
Day Low | $0.18 | EPS | $0.00 | |||
Volume | 1,005,451 |